Rituximab is a monoclonal antibody against the protein CD20, which is primarily
found on the surface of immune system B cells. Rituximab destroys B cells and ...
Find patient medical information for rituximab intravenous on WebMD including
its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Rituximab injection is used alone or with other medicines to treat a type of cancer
called non-Hodgkin's lymphoma (NHL). It helps the immune system destroy ...
Jun 20, 2016 ... Consumer information about Rituximab (Rituxan), drug prescription drug used to
treat non-Hodgkin's B-cell lymphomas, chronic lymphocytic ...
Facts for patients and caregivers about the drug Rituximab (Rituxan, MabThera)
such as common usages and dosages, safety tips and side effects.
Oct 5, 2006 ... This page contains brief information about rituximab and a collection of links to
more information about the use of this drug, research results, ...
RITUXAN®. RITUXAN® (rituximab) injection, for intravenous use ... Rituxan® (
rituximab) is a CD20-directed cytolytic antibody indicated for the treatment of ...
Jan 15, 2014 ... You may experience a serious reaction while you receive or within 24 hours after
receiving a dose of rituximab injection. These reactions ...
Rituximab. (ri TUK si mab). Trade name: Rituxan<sup>®</sup>. Chemocare.com uses generic
names in all descriptions of drugs. Rituxan is the trade name for rituximab.
Rituxan (rituximab) is a cancer medicine that interferes with the growth and
spread of cancer cells in the body. Rituxan is used to treat non-Hodgkin's